Activist investor Carl Icahn has dropped his controversial opposition to the merger of insurer Cigna and pharmacy benefit manager Express Scripts, after previously bashing the $60 billion deal.
Icahn’s investment firm said in a statement late Monday that he was abandoning his attempt to stop the deal, but did not elaborate. Icahn holds a small stake in Cigna.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.